Drugs & Targets ColoAlert colorectal screening test receives approval in Switzerland September 05, 2025Vol.51 No.32
Drugs & TargetsFree FDA gives accelerated approval to Modeyso as the first and only treatment for recurrent H3 K27M-mutant diffuse midline glioma August 08, 2025Vol.51 No.31
Drugs & Targets FDA grants priority review for Imfinzi in gastric and GEJ cancer August 01, 2025Vol.51 No.30
Drugs & Targets EC approves Sarclisa in combination with VRd for transplant-eligible newly diagnosed MM August 01, 2025Vol.51 No.30
Drugs & Targets FDA extends review period for Blenrep combinations after unfavorable ODAC vote, EU approval July 25, 2025Vol.51 No.29By Jacquelyn Cobb
Drugs & Targets FDA issues CRL for RP1+ nivolumab BLA for treatment of advanced melanoma July 25, 2025Vol.51 No.29
Drugs & Targets FDA grants Breakthrough Therapy designation to elironrasib for lung cancer July 25, 2025Vol.51 No.29
Drugs & Targets EMA grants Orphan Drug designation for ICT01 as treatment for AML July 25, 2025Vol.51 No.29
Drugs & Targets FDA gives TAR-200 Priority Review for invasive bladder cancer July 18, 2025Vol.51 No.28
